GENMAB A/S/S (OTCMKTS:GMXAY) shares traded down 4% during mid-day trading on Monday . The stock traded as low as $31.85 and last traded at $31.99, 440,050 shares traded hands during mid-day trading. An increase of 806% from the average session volume of 48,553 shares. The stock had previously closed at $33.32.

The stock’s 50 day simple moving average is $28.56.

About GENMAB A/S/S (OTCMKTS:GMXAY)

Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).

Read More: Are we seeing the beginning of a new bubble?

Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.